About Fractyl Laboratories
Fractyl Health develops innovative medical device solutions for the treatment of chronic diseases. The growing product pipeline leverages our minimally invasive procedural therapy, Revita DMR (Duodenal Mucosal Resurfacing), which is designed to rejuvenate the lining of the duodenum and improve patient health. They envision a world with better solutions to chronic diseases through the use of less invasive, device-based therapies that will lessen the burden on patients, physicians, and payers. Fractyl Health aims to bring curative therapies to the large populations of patients with metabolic disease.
Company details
Funding
Total raised
$300.4M
Last stage
Public
Investors
Founders
Jay Caplan
Co-Founder, President, and Chief Product Officer of Fractyl Health. Has held leadership positions in the medical device field for more than 20 years.
Harith Rajagopalan
M.D., Ph.D. Co-founder and CEO of Fractyl Health. Started the company while serving as an Entrepreneur-in-Residence at General Catalyst Partners. Former academic cardiologist and physician-scientist; B.S. in chemistry from Stanford, M.D. and Ph.D. from Johns Hopkins School of Medicine.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.